Uncovering Promising Penny Stocks For November 2024

Global markets have experienced significant shifts recently, with U.S. stocks reaching record highs following a "red sweep" in the elections, leading to optimism about potential growth and tax reforms. Amidst these broader market dynamics, investors may find opportunities in penny stocks—smaller or newer companies that can offer unique growth prospects. Although the term "penny stocks" might seem outdated, these investments remain relevant for those seeking value and potential upside at lower price points. In this article, we explore three promising penny stocks that stand out for their financial strength and growth potential.

Top 10 Penny Stocks

Name	Share Price	Market Cap	Financial Health Rating
BP Plastics Holding Bhd (KLSE:BPPLAS)	MYR1.24	MYR349.03M	★★★★★★
Rexit Berhad (KLSE:REXIT)	MYR0.79	MYR136.84M	★★★★★★
Lever Style (SEHK:1346)	HK$0.83	HK$526.87M	★★★★★★
DXN Holdings Bhd (KLSE:DXN)	MYR0.495	MYR2.46B	★★★★★★
Embark Early Education (ASX:EVO)	A$0.76	A$139.45M	★★★★☆☆
Wellcall Holdings Berhad (KLSE:WELLCAL)	MYR1.53	MYR761.86M	★★★★★★
Hil Industries Berhad (KLSE:HIL)	MYR0.87	MYR288.79M	★★★★★★
Seafco (SET:SEAFCO)	THB2.12	THB1.72B	★★★★★★
Kelington Group Berhad (KLSE:KGB)	MYR2.96	MYR2.04B	★★★★★☆
Next 15 Group (AIM:NFG)	£3.87	£377.93M	★★★★☆☆

Click here to see the full list of 5,738 stocks from our Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Deceuninck (ENXTBR:DECB)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Deceuninck NV designs, manufactures, recycles, and distributes multi-material window, door, and building solutions across Europe, North America, Turkey, and internationally with a market cap of €323.85 million.

Operations: The company's revenue is primarily derived from its Window and Door Systems segment, generating €788.34 million, followed by Home Protection at €44.13 million and Outdoor Living at €27.98 million.

Market Cap: €323.85M

Deceuninck NV, with a market cap of €323.85 million, operates in the building solutions sector and recently reported half-year sales of €421.57 million, slightly down from the previous year. The company's financial health shows mixed signals; while its debt is well covered by operating cash flow and interest payments are manageable, it carries a high net debt to equity ratio of 41.7%. Despite negative earnings growth over the past year, Deceuninck's earnings have grown by 13.8% annually over five years. However, recent results were impacted by a significant one-off loss of €19.7 million as of June 2024.

• Navigate through the intricacies of Deceuninck with our comprehensive balance sheet health report here.
• Understand Deceuninck's earnings outlook by examining our growth report.

Scales (NZSE:SCL)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Scales Corporation Limited operates in the manufacture and trading of food ingredients across New Zealand, Asia, Europe, North America, and other international markets with a market cap of NZ$585.77 million.

Operations: The company's revenue is derived from three main segments: Horticulture, contributing NZ$221.86 million; Global Proteins, with NZ$289.15 million; and Logistics, generating NZ$94.55 million.

Market Cap: NZ$585.77M

Scales Corporation Limited, with a market cap of NZ$585.77 million, has shown financial improvements, reporting half-year sales of NZ$318.1 million and net income of NZ$28.15 million as of June 2024, up from the previous year. The company became profitable this year and is forecasted to grow earnings by 13.17% annually. Its debt levels are manageable with interest payments well covered by EBIT at 12.7 times coverage and operating cash flow adequately covering debt at 70.7%. However, a large one-off gain of NZ$11 million influenced recent earnings results, highlighting potential volatility in financial performance.

• Click to explore a detailed breakdown of our findings in Scales' financial health report.
• Learn about Scales' future growth trajectory here.

Vista Group International (NZSE:VGL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Vista Group International Limited offers software and data analytics solutions to the global film industry, with a market cap of NZ$691.64 million.

Operations: The company's revenue segments include NZ$11.7 million from Mexico, NZ$25.6 million from New Zealand, NZ$51.7 million from the United States, and NZ$38.4 million from the United Kingdom.

Market Cap: NZ$691.64M

Vista Group International, with a market cap of NZ$691.64 million, is currently unprofitable but shows potential for growth. Despite its losses increasing over the past five years, the company's earnings are forecasted to grow significantly at 59.87% annually. Its debt situation is manageable with operating cash flow covering 28.9% of its debt and short-term assets exceeding both short-term and long-term liabilities, indicating financial stability in the near term. Recent investor activism led by Admetus Capital Limited has been resolved without changes to the board composition, potentially allowing management to focus on strategic initiatives moving forward.

• Take a closer look at Vista Group International's potential here in our financial health report.
• Review our growth performance report to gain insights into Vista Group International's future.

Make It Happen

• Click this link to deep-dive into the 5,738 companies within our Penny Stocks screener.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com